• Leading U.S. provider of consumer products in cannabis, Curaleaf Holdings, Inc. acquires Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German manufacturer and distributor of medical cannabis
• The acquisition underscores Curaleaf’s aspiration to be the major player in the European cannabis market
• Ebner Stolz supported the transaction with a Financial and Tax Due Diligence as well as SPA support

Stuttgart, Germany, August 18, 2022 - The auditing and consulting firm Ebner Stolz has assisted Curaleaf Holdings, Inc. (Curaleaf) in the acquisition of a 55% stake in the German medical cannabis producer and distributor Four 20 Pharma GmbH (Four 20 Pharma) with a Financial and Tax Due Diligence.

Curaleaf Holdings is a leading international provider of consumer products in cannabis, listed on the Canadian Securities Exchange. Curaleaf and its brands provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 22 states with 136 dispensaries, 26 cultivation sites, and employs over 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network.

Four 20 Pharma is a fully EU-GMP and GDP licensed European producer and distributor of medical cannabis, headquartered in Paderborn, Germany, providing industry-leading product quality and best-in-class regulatory expertise. In 2020, Four 20 Pharma entered the German market with the launch of its 420NATURAL brand. The company has created a steady supply chain by sourcing from top EU-GMP certified suppliers around the world to deliver cannabis products to its customers.

This strategic transaction underscores Curaleaf’s aspiration to be the major player in the European market. Curaleaf's European business will immediately gain additional critical mass while the company will be in a superior position to capitalize on the accelerating trends in the European cannabis market.

As part of the transaction, Ebner Stolz provided comprehensive Financial and Tax Due Diligence advice as well as SPA support to Curaleaf together with the Boston Office of Nexia partner CohnReznick LLP.

Team Ebner Stolz: Christian Fuchs (Project-leading Partner, Financial Due Diligence, SPA support), Florian Seizer (Project Lead, Financial Due Diligence, SPA support), Jan-Niklas Herden (Financial Due Diligence), Alexander Euchner (Partner, Tax Due Diligence), Tobias Schupp (Tax Due Diligence)

Pressekontakt

Henning Marburger
Ebner Stolz
Holzmarkt 1
50676 Cologne
Germany
Phone: +49 221 20643-628
henning.marburger@ebnerstolz.de

Unternehmenskontakt

Christian Fuchs
Ebner Stolz
Kronenstraße 30
70174 Stuttgart
Germany
Phone +49 711 2049-1276
christian.fuchs@ebnerstolz.de 

About Ebner Stolz

Ebner Stolz is one of the largest independent mid-market auditing and consulting firms in Germany and ranks among the top ten in the industry. The firm has decades of in-depth experience in auditing, tax consulting, legal consulting and management consulting. This broad spectrum is offered by 1,900 employees in the typical multidisciplinary approach in all major German cities and business centers. As a market leader in the SME sector, the firm primarily serves mid-sized industrial, commercial and service enterprises of all sizes and in every sector.

Ebner Stolz conducts cross-border audit and consulting engagements together with partners from Nexia International, one of the world's ten largest networks of consulting and auditing firms. Through Nexia, Ebner Stolz is represented in over 125 countries with 790 offices.